Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Doxycycline hyclate delayed released

Phase 3Small molecule

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Sexually Transmitted InfectionsNot yet recruiting

Sexually Transmitted InfectionsPhase 3

Not yet recruiting

Timeline

Expected Milestones

Q2 2028

Post-ApprovalNot yet recruiting

Sexually Transmitted Infections

NCT06738407

Clinical

Trials by Indication[1]

Sexually Transmitted Infections1 trial

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections

Not yet recruiting·WWestat·Phase 4·NCT06738407·760 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Doxycycline hyclate delayed released. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Doxycycline hyclate delayed released compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Doxycycline hyclate delayed released. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Westat company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: WWestat

Related News